Drug Channels Archive for September, 2026

Click a link below to view the mailing archive as if it had been sent to you.

2026-09-29 07:47		Drug Channels - Drug Channels News Roundup, September 2026: The 340B Margin Squeeze, Economics of Cutting List Price, Patient Adherence from Copay Cards, Negative Part D Premiums, and Drug Channel Dating Profiles
2026-09-25 07:47		Drug Channels - Why GoodRx Is Built for the AI-Driven Patient Journey
2026-09-22 07:47		Drug Channels - The Spinoff: How Biosimilars Are Becoming Wholesalers' Next Hit Show
2026-09-21 07:47		Drug Channels - Keep Your Patient Program at the Forefront of Innovation at Patient Pathways: The Copay and Patient Services Congress
2026-09-18 07:47		Drug Channels - Fixing the Front Door Isn't the Same as Fixing Time to Therapy
2026-09-15 07:47		Drug Channels - Preorder DCI's New 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
2026-09-14 07:47		Drug Channels - Informa Connect's Pharma/Biotech GTN Summit
2026-09-09 07:47		Drug Channels - Drug Channels Leadership Forum 2027: Antonio Ciaccia to Serve as Moderator
2026-09-03 07:47		Drug Channels - BlinkRx Insights: Beyond the Hub - Rethinking the Prescription Journey
2026-09-01 07:47		Drug Channels - The Private Label Biosimilar Paradox in Medicare Part D